...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith-Oncology Pipeline
6
Mar 16, 2021 08:18AM
9
Mar 18, 2021 03:12PM
6
Mar 18, 2021 04:01PM

RVXOT, when you get to the "promissory note" type of financing and not knowing the conditions set with it, that doesn't sound very optimistic going forward. 

The Zenith OTC market may have caught Don by total surprise.  As you said, Don now needs some event that would support an SPP on the open market, for a hell of a lot more than what shares are going for on the OTC market.

A total sale of Zenith is where it's at for the longs as I see it. I'm not one of them. I'm picking what I can on the OTC seeing that Don did not set up an IPO as he said he would years ago. I am sure he waiting for a successful RVX BOM to launch the Zenith IPO and unfortunately, that did not materialize. 

 

Koo

6
Mar 18, 2021 06:27PM
2
Mar 19, 2021 06:49AM
4
Mar 19, 2021 11:19AM
5
Mar 19, 2021 11:23AM
6
Mar 19, 2021 11:57AM
2
Mar 22, 2021 04:08PM
3
Mar 22, 2021 05:34PM
2
Mar 23, 2021 05:33AM
5
Mar 23, 2021 07:54AM
4
Mar 23, 2021 09:16AM
8
Mar 23, 2021 01:45PM
4
Mar 23, 2021 02:24PM
2
Mar 23, 2021 03:27PM
2
Mar 23, 2021 04:33PM
Share
New Message
Please login to post a reply